Aduro Biotech

ADRO NASDAQ
1.790
-0.070
-3.76%
已收盘, 16:23 06/14 EDT
开盘
1.830
昨收
1.860
最高
1.890
最低
1.750
成交量
24.47万
成交均量(3M)
44.04万
52周最高
8.99
52周最低
1.700
换手率
0.31%
市值
1.43亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Aduro Biotech ADRO股票价格,Aduro Biotech股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Aduro Biotech, Inc. is an immunotherapy company, which focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, including cancer. The Company's product candidates from its Live, Attenuated, Double-Deleted (LADD) Listeria monocytogenes, Stimulator of Interferon Genes Pathway Activator, and B-select monoclonal antibody platforms are designed to stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies, as well as other immunotherapies. Its LADD technology platform is being developed as a treatment for multiple indications, including mesothelioma, ovarian, gastric, lung and prostate cancers. Its LADD product candidate is CRS-207, which is being developed as a treatment for multiple indications, including mesothelioma, ovarian and gastric cancers. ADU-214 and ADU-741 are product candidates in development for lung and prostate cancers, respectively.
展开 >

最近浏览

名称
价格
涨跌幅